Online citations, reference lists, and bibliographies.
← Back to Search

Value Of PAX8, PAX2, Napsin A, Carbonic Anhydrase IX, And Claudin-4 Immunostaining In Distinguishing Pleural Epithelioid Mesothelioma From Metastatic Renal Cell Carcinoma

N. Ordóñez
Published 2013 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Both mesotheliomas and renal cell carcinomas can present a wide variety of cytomorphologic features and histologic patterns. Because of this, renal cell carcinomas metastatic to the pleura and lung can be confused with mesotheliomas. Recently, a variety of positive carcinoma markers, including kidney-associated markers, have become available. The aim of this study is to investigate the value of some of these markers, specifically PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4, for assisting in distinguishing pleural epithelioid mesotheliomas from metastatic renal cell carcinomas. To do so, a total of 40 pleural epithelioid mesotheliomas and 55 renal cell carcinomas (33 clear cell, 10 papillary, and 12 chromophobe) were investigated. In all, 91% of the renal cell carcinomas expressed claudin-4, 89% PAX8, 60% PAX2, 71% carbonic anhydrase IX, and 29% napsin A. All of the mesotheliomas were positive for carbonic anhydrase IX and were negative for all of the other markers. On the basis of these results, it is concluded that claudin-4 and PAX8 have a higher sensitivity and specificity for assisting in discriminating between pleural epithelioid mesotheliomas and renal cell carcinomas when compared with all of the other positive carcinoma markers that are, at present, recommended to be included in the immunohistochemical panels used in this differential diagnosis. Even though PAX2 and napsin A are highly specific, because of their low sensitivity, they have only a limited value. Carbonic anhydrase IX is not useful.
This paper references
HBME‐1, MOC‐31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma
Oates (2000)
Calretinin and Other Mesothelioma Markers in Synovial Sarcoma: Analysis of Antigenic Similarities and Differences With Malignant Mesothelioma
M. Miettinen (2001)
Value of PAX 8 Immunostaining in Tumor Diagnosis: A Review and Update
N. Ordóñez (2012)
Pax-2 expression in adult renal tumors.
L. Daniel (2001)
Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas.
H. Frierson (2003)
Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
S. Liao (1997)
Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy.
J. Mittag (2007)
Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
J. Tostain (2010)
The value of antibodies 44-3A6, SM3, HBME-1, and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: a comparative study with other commonly used antibodies.
N. Ordóñez (1997)
Calretinin: a novel immunocytochemical marker for mesothelioma.
C. Doglioni (1996)
The Immunohistochemical Diagnosis of Mesothelioma: A Comparative Study of Epithelioid Mesothelioma and Lung Adenocarcinoma
N. Ordóñez (2003)
PAX8 Reliably Distinguishes Ovarian Serous Tumors From Malignant Mesothelioma
Anna R. Laury (2010)
Combination of Napsin A and TTF-1 Immunohistochemistry Helps in Differentiating Primary Lung Adenocarcinoma From Metastatic Carcinoma in the Lung
J. Ye (2011)
The utility of PAX-2 and renal cell carcinoma marker Modern Pathology
SG Sharma (2013)
Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.
A. Husain (2013)
HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura.
A. Kennedy (1997)
Expression of PAX8 in Normal and Neoplastic Tissues: A Comprehensive Immunohistochemical Study
D. Tacha (2011)
Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas
N. Ordóñez (2013)
Compar - ison of putative renal cell carcinoma ( RCC ) immunohistochemical ( IHC ) markers in primary adrenal cortical lesions ( ACL ) and metastatic RCC : a tissue microarray study of 246 cases
JK McKenney (2009)
Pax-2 controls multiple steps of urogenital development.
M. Torres (1995)
Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases.
M. Wick (1990)
Carbonic Anhydrase IX Expression in Clear Cell Renal Cell Carcinoma: An Immunohistochemical Study Comparing 2 Antibodies
H. Al-Ahmadie (2008)
International renal‐cell cancer study. IV. Occupation
J. S. Mandel (1995)
Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.
B. Leibovich (2007)
PAX-2 Expression in Non-neoplastic, Primary Neoplastic, and Metastatic Neoplastic Tissue: A Comprehensive Immunohistochemical Study
Q. J. Zhai (2010)
Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update.
N. Ordóñez (2013)
Distribution of Cytokeratins and Vimentin in Adult Renal Neoplasms and Normal Renal Tissue: Potential Utility of a Cytokeratin Antibody Panel in the Differential Diagnosis of Renal Tumors
B. Skinnider (2005)
Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura
Y. Soini (2006)
The Value of Immunocytochemistry in Distinguishing Between Clear Cell Carcinoma of the Kidney and Ovary
L. Nolan (2001)
CD10 is expressed in a subset of chromophobe renal cell carcinomas
G. Martignoni (2004)
Parvalbumin Is Constantly Expressed in Chromophobe Renal Carcinoma
G. Martignoni (2001)
Distant visceral metastases in pleural mesothelioma.
G. H. Roberts (1976)
Diagnosing Primary and Metastatic Renal Cell Carcinoma: The Use of the Monoclonal Antibody `Renal Cell Carcinoma Marker'
D. K. McGregor (2001)
Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Müllerian system origin?
G. Tong (2007)
Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
C. Comin (2001)
The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study.
N. Ordóñez (2004)
Renal Cell Carcinoma Antigen Is Expressed by Yolk Sac Tumors and Yolk Sac Elements of Embryonal Carcinomas
M. Yan (2003)
cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma.
S. Y. Xiao (2001)
A comparative immunohistochemical study of malignant mesothelioma and renal cell carcinoma: the diagnostic utility of Leu‐M1, Ber EP4, Tamm‐Horsfall protein and thrombomodulin
R. Attanoos (1995)
Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.
R. Brown (1993)
Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma.
N. Ordóñez (2000)
Application of Mesothelin Immunostaining in Tumor Diagnosis
N. Ordóñez (2003)
Human carbonic anhydrases and carbonic anhydrase deficiencies.
W. Sly (1995)
Mesothelioma with clear cell features: an ultrastructural and immunohistochemical study of 20 cases.
N. Ordóñez (2005)
Immunohistochemical localization of napsin and its potential role in protein catabolism in renal proximal tubules.
K. Mori (2002)
Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma.
L. Memeo (2007)
Utility of WT‐1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions
Robert T. Pu (2008)
Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C‐kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics
Jason C. Carvalho (2011)
Foamy cell mesothelioma
A. Cavazza (2002)
Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.
S. Ivanov (2001)
Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma.
T. Hirano (2003)
PAX2(−)/PAX8(−)/Inhibin A(+) Immunoprofile in Hemangioblastoma: A Helpful Combination in the Differential Diagnosis With Metastatic Clear Cell Renal CellCarcinoma to the Central Nervous System
E. Carney (2011)
Metanephric Adenoma, Nephrogenic Rests, and Wilms' Tumor: A Histologic and Immunophenotypic Comparison
T. Muir (2001)
The immunohistochemical diagnostic panel for epithelial mesothelioma: a reevaluation after heat-induced epitope retrieval.
J. R. Riera (1997)
PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study
A. Ozcan (2011)
A monoclonal antibody to human acute lymphoblastic leukaemia antigen
J. Ritz (1980)
Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study
G. Tong (2009)
Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples.
A. Lugli (2003)
Comparison of PAX‐2, RCC antigen, and antiphosphorylated H2AX antibody (γ‐H2AX) in diagnosing metastatic renal cell carcinoma by fine‐needle aspiration
Matthew J. Wasco (2008)
Napsin A expression in lung and kidney neoplasia: a review and update.
N. Ordóñez (2012)
Metastatic renal cell carcinoma presenting as multiple pleural tumours
H. Ohnishi (2005)
Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis.
L. Liu (2007)
Value of Mesothelin Immunostaining in the Diagnosis of Mesothelioma
N. Ordóñez (2003)
Distinguishing Clear Cell Renal Cell Carcinoma, Retroperitoneal Paraganglioma, and Adrenal Cortical Lesions on Limited Biopsy Material: Utility of Immunohistochemical Markers
James Lapinski (2010)
Renal cell carcinoma marker reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell carcinoma
B. Ingold (2008)
The use of the monoclonal antibody mesothelin in the diagnosis of malignant mesothelioma in pleural biopsies
M. Galloway (2006)
Differential Immunoprofiles of Hepatocellular Carcinoma, Renal Cell Carcinoma, and Adrenocortical Carcinoma: A Systemic Immunohistochemical Survey Using Tissue Array Technique
Chin-Chen Pan (2005)
Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours
Y. Soini (2005)
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma
Albert Y Chu (2005)
Immunohistochemical Profile of Common Epithelial Neoplasms Arising in the Kidney
M. Kim (2002)
Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma.
N. Ordóñez (1998)
Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions
F. Facchetti (2007)
Immunohistochemical Distinction of Primary Adrenal Cortical Lesions From Metastatic Clear Cell Renal Cell Carcinoma: A Study of 248 Cases
A. Sangoi (2011)
Immunohistochemical Analysis of Mucinous Tubular and Spindle Cell Carcinoma and Papillary Renal Cell Carcinoma of the Kidney: Significant Immunophenotypic Overlap Warrants Diagnostic Caution
G. Paner (2006)
The Immunohistochemical Diagnosis of Mesothelioma: Differentiation of Mesothelioma and Lung Adenocarcinoma
N. Ordóñez (1989)
Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.
A. Osunkoya (2009)
Expression of Calretinin, Thrombomodulin, Keratin 5, and Mesothelin in Lung Carcinomas of Different Types: An Immunohistochemical Analysis of 596 Tumors in Comparison With Epithelioid Mesotheliomas of the Pleura
M. Miettinen (2003)
Pax2 in development and renal disease.
G. Dressler (1999)
PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases
M. Fujiwara (2010)
The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases
C. Pan (2004)
International renal-cell cancer
JS Mandel (1995)
The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study
N. Ordóñez (2006)
The Utility of PAX-2 in Distinguishing Metastatic Clear Cell Renal Cell Carcinoma From its Morphologic Mimics: An Immunohistochemical Study With Comparison to Renal Cell Carcinoma Marker
N. Gokden (2008)
Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma.
N. Ordóñez (1998)
Immunohistochemical Panels For Differentiating Epithelial Malignant Mesothelioma From Lung Adenocarcinoma: A Study With Logistic Regression Analysis
R. Carella (2001)
Clear Cell Meningioma: A Clinicopathologic Study of 18 Tumors and Examination of the Use of CD10, CA9, and RCC Antibodies to Distinguish Between Clear Cell Meningioma and Metastatic Clear Cell Renal Cell Carcinoma
R. Prayson (2010)
Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study
P. Mazal (2005)
Roles of Pax-genes in developing and adult brain as suggested by expression patterns
A. Stoykova (1994)
Metastatic renal cell carcinoma mimicking pleural mesothelioma.
T. Azuma (1999)
Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma.
C. L. Collins (1992)
Xp11 Translocation Renal Cell Carcinoma (RCC): Extended Immunohistochemical Profile Emphasizing Novel RCC Markers
P. Argani (2010)
Diagnostic Implications of Transcription Factor Pax 2 Protein and Transmembrane Enzyme Complex Carbonic Anhydrase IX Immunoreactivity in Adult Renal Epithelial Neoplasms
R. Gupta (2009)
Napsin A (TA02) is a useful alternative to thyroid transcription factor‐1 (TTF‐1) for the identification of pulmonary adenocarcinoma cells in pleural effusions
A. Dejmek (2007)
Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma
A. Rivera (2010)
The utility of napsin‐A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas
L. Stoll (2010)
Immunohistochemistry for the detection of renal cell carcinoma in effusion cytology
D. Chute (2011)
Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma
J. Leppert (2005)
Metastatic renal cell carcinoma mimicking pleural mesothelioma.
D. R. Taylor (1987)
Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms.
A. Avery (2000)
Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas.
N. Ordóñez (2005)
Profiling and classification tree applied to renal epithelial tumours
Y. Allory (2008)
Value of PAX2 Immunostaining in Tumor Diagnosis: A Review and Update
N. Ordóñez (2012)
CD10 is a diagnostic and prognostic marker in renal malignancies
C. Langner (2004)
‘Pseudomesotheliomatous’ carcinomas of the pleura: a 10‐year analysis of cases from the Environmental Lung Disease Research Group, Cardiff
R. Attanoos (2003)
Role of Carbonic Anhydrase IX in Human Tumor Cell Growth, Survival, and Invasion
N. Robertson (2004)
The value of 'mesothelium-associated' antibodies in distinguishing between metastatic renal cell carcinomas and mesotheliomas.
M. Osborn (2002)
Expression of renal cell carcinoma-associated markers erythropoietin, CD10, and renal cell carcinoma marker in diffuse malignant mesothelioma and metastatic renal cell carcinoma.
K. Butnor (2006)
PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin.
A. Ozcan (2009)
The Value of Immunocytochemistry in Distinguishing Between Clear Cell Carcinoma of the Kidney and Ovary
Nolan Lp (2001)
Expression of Renal Cell Carcinoma Antigen (RCC) in Renal Epithelial and Nonrenal Tumors: Diagnostic Implications
N. Bakshi (2007)
Immunohistochemical diagnosis of renal neoplasms.
L. Truong (2011)
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
J. Bishop (2010)
Kidney cancer and occupational exposure to asbestos: a meta-analysis of occupational cohort studies
D. Sali (2004)
Metanephric adenoma, nephrogenic rests, and Wilms’ tumor: a histologic Modern Pathology
TE Muir (2013)
The Utility of Pax-2 and Renal Cell Carcinoma Marker Immunohistochemistry in Distinguishing Papillary Renal Cell Carcinoma From Nonrenal Cell Neoplasms With Papillary Features
S. Sharma (2010)
Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.
E. Genega (2010)
Monoclonal antibody to a proximal nephrogenic renal antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human renal cell carcinomas.
S. Yoshida (1989)
Thoracic manifestations of renal cell carcinoma.
A. Latour (1976)
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer
C. Potter (2003)
Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung
Mitchell L. Ramsey (2011)
Caveolin‐1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma
V. Amatya (2009)
CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms
W. G. McCluggage (2001)

This paper is referenced by
Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with specificity test in genitourinary tumors.
N. Sharifai (2020)
Claudin-4 Shows Superior Specificity for Mesothelioma vs Non-Small Cell Lung Carcinoma Compared to MOC-31 and Ber-EP4.
Julia R Naso (2020)
Pathological Diagnosis of Mesothelioma
G. Fontanini (2019)
CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients
L. Thompson (2018)
Handbook of Practical Fine Needle Aspiration and Small Tissue Biopsies
Ph.D. Fan Lin (2018)
Metastatic Carcinoma of Unknown Primary: Diagnostic Approach Using Immunohistochemistry
J. Conner (2015)
Introduction and Application of Fine Needle Aspiration Biopsy
F. Lin (2018)
CD24 is highly useful in differentiating high-grade serous carcinoma from benign and malignant mesothelial cells.
B. Davidson (2016)
Unknown Primary/Undifferentiated Neoplasm
F. Lin (2015)
Broad-spectrum immunohistochemical epithelial markers: a review.
N. Ordóñez (2013)
Claudin‐4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology
V. Jo (2014)
Napsin A expression in small cell carcinoma of the lung: a cytologic study with review of differentials.
K. Hookim (2014)
Value of Calretinin Immunostaining in Diagnostic Pathology: A Review and Update
N. Ordóñez (2014)
Evaluation of Small Biopsy Material in Patients with Multiple and Secondary Tumors
S. Monaco (2015)
Exfoliative Cytology and Effusions
S. Meschter (2015)
Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma
Tyler J. Peat (2017)
The diagnostic role of PTEN and ARID1A in serous effusions
B. Davidson (2017)
Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study.
N. Ordóñez (2014)
Immunohistochemistry in Peritoneal Mesothelioma: A Single-Center Experience of 244 Cases.
R. Tandon (2018)
The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review.
G. Alí (2018)
The diagnostic role of BAP1 in serous effusions.
B. Davidson (2018)
The Diagnosis of Pleural Tumors Other Than Mesothelioma.
R. Attanoos (2018)
Immunohistochemistry in undifferentiated neoplasm/tumor of uncertain origin.
Fan Li-n (2014)
Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
J. Ramos-Vara (2016)
Semantic Scholar Logo Some data provided by SemanticScholar